Legal Representation
Attorney
WILLIAM G. GILTINAN
USPTO Deadlines
Next Deadline
14 days remaining
NOA E-Mailed - SOU Required
Due Date
August 04, 2025
Extension Available
Until February 04, 2026
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 4, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 13, 2024 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Nov 13, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 18, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 18, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 18, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 6, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| May 6, 2024 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| May 6, 2024 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| May 6, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Feb 5, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Feb 5, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Nov 6, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 6, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 6, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 27, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Oct 27, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 27, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 27, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 27, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 4, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 3, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 3, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 8, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jun 8, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Mar 11, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 11, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 11, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 7, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 24, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 21, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and medicines for use in the treatment of a wide variety of human medical conditions administered via pulmonary and nasal delivery, injectable delivery, or transdermal delivery; Pharmaceutical preparations and medicines administered via pulmonary and nasal delivery, injectable delivery, or transdermal delivery, for use in treating human medical conditions, namely, dermatological conditions, wounds and tissue trauma, pain, migraines, neurological disorders, seizures, chemical addiction, central nervous system conditions, musculoskeletal conditions, osteoporosis, oral and gastrointestinal conditions, hormonal imbalances and replacement, reproductive disorders, menopause, cardiovascular conditions, infectious diseases, respiratory conditions, asthma, COPD, allergies, inflammatory, immune, and autoimmune conditions, metabolic andendocrine conditions, diabetes, cancer and neoplasms, poisoning, and human medical conditions of unknown or disputed aetiology; Human vaccine preparations; Antidotes
Class 010
Injection device for pharmaceuticals, namely, medical auto-injectors; Medical auto injectors; syringes for medical purposes and for injections, namely, auto-injector medical syringes
Class 040
Custom manufacture of pharmaceutical preparations
Class 042
Development of pharmaceutical preparations
Classification
International Classes
005
010
040
042